CD22 and acute lymphoblastic leukemia: The earliest B-lineage markers are CD19, CD22 (membrane and cytoplasm) and CD79a.14,15 A positive reaction for any two of these three markers, without further differentiation markers, identifies pro-B ALL (EGIL B-I subtype) (Figure 3A).